In acute pancreatitis, mild obesity might more than double the odds of vital organ failure, according to an international study analyzing data from over 2200 patients by researchers at Semmelweis University. The study, published in the journal Pancreatology, found that patients with obesity may have more than three times the odds of developing severe acute pancreatitis compared with patients of normal weight. Experts therefore emphasize that even a gradual or smaller weight loss might reduce the odds of severe complications.

The intestine engages in communication with various distant organs through neural, immune, and endocrine pathways. This systemic interconnection mechanism is referred to as the gut-organ axis, in which gut microbiota play a central role. The therapeutic landscape is rapidly evolving, with next-generation probiotics, postbiotics, and engineered strains now enabling precise, targeted remodeling of the gut ecosystem to restore host homeostasis and treat multi-organ diseases. This review articulates how the gut microbiota integrates environmental cues into a multi-organ regulatory network, underscoring its potential as a therapeutic target for systemic diseases.